cdc25 cell cycle-activating phosphatases and c-myc expression in human non-Hodgkin's lymphomas

Cancer Research

Volumn 58, Issue 8, 1998, Pages 1762-1767

  Hernández, Silvia ^a   Hernández, Luis ^a   Beà, Sílvia ^a   Cazorla, Maite ^a   Fernández, Pedro L ^a   Nadal, Alfons ^b   Muntané, Jaume ^a   Mallofré, Carme ^a   Montserrat, Emilio ^a   Cardesa, Antonio ^a   Campo, Elías ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; DNA; MESSENGER RNA; PHOSPHATASE;

ARTICLE; CELL CYCLE; CHRONIC LYMPHATIC LEUKEMIA; ENZYME ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; ONCOGENE; ONCOGENE C MYC; PRIORITY JOURNAL;

BLOTTING, NORTHERN; BLOTTING, SOUTHERN; CDC25 PHOSPHATASE; CELL CYCLE PROTEINS; DNA, NEOPLASM; FLOW CYTOMETRY; HUMANS; LYMPHOMA, NON-HODGKIN; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN-TYROSINE-PHOSPHATASE; PROTO-ONCOGENE PROTEINS C-MYC; RNA, NEOPLASM;

EID: 2642656324     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. 2. Proc. Natl. Acad. Sci. USA, 87: 5139-5143, 1990.
2. Galaktionov, K., and Beach, D. Specific activation of cdc25 tyrosine phosphatases by B-type cyclins: evidence for multiple roles of mitotic cyclins. Cell, 67: 1181-1194, 1991.
3. 2 delay induced by the exogenous factors epidermal growth factor and phorbolester. J. Cell Physiol., 168: 589-599, 1996.
4. Jinno, S., Suto, K., Nagata, A., Igarashi, M., Kanaoka, Y., Nojima, H., and Okayama, H. Cdc25A is a novel phosphatase functioning early in the cell cycle. EMBO J., 13: 1549-1556, 1994.
5. Galaktionov, K., Lee, A. K., Eckstein, J., Draetta, G., Meckler, J., Loda, M., and Beach, D. CDC25 phosphatases as potential human oncogenes. Science (Washington DC), 269: 1575-1577, 1995.
6. Spitkovsky, D., Jansen-Durr, P., Karsenti, E., and Hoffman, I. S-phase induction by adenovirus E1A requires activation of cdc25A tyrosine phosphatase. Oncogene, 12: 2549-2554, 1996.
7. Nagata, A., Igarashi, M., Jinno, S., Suto, K., and Okayama, H. An additional homolog of the fission yeast cdc25+ gene occurs in humans and is highly expressed in some cancer cells. New Biol., 3: 959-968, 1991.
8. Gasparotto, D., Maestro, R., Piccinin, S., Vulkosavljevic, T., Barzan, L., Sulfaro, S., and Boiocchi, M. Overexpression of CDC25A and CDC25B in head and neck cancers. Cancer Res., 57: 2366-2368, 1997.
9. Blackwell, T. K., Kretzner, L., Blackwood, E. M., Eisenman, R. N., and Weintraub, H. Sequence-specific DNA binding by the c-myc protein. Science (Washington DC), 250: 1149-1151, 1990.
10. Marcu, K. B., Bossone, S. A., and Patel, A. J. Myc function and regulation. Annu. Rev. Biochem., 61: 809-860, 1992.
11. Stone, J., de Lange, T., Ramsay, G., Jakobovits, E., Bishop, J. M., Varmus, H., and Lee, W. Definition of regions in human c-myc that are involved in transformation and nuclear localization. Mol. Cell. Biol., 7: 1697-1709, 1987.
12. Amati, B., Dalton, S., Brooks, M. W., Littlewood, T. D., Evan, G. I., and Land, H. Transcriptional activation by the human c-myc oncoprotein in yeast requires interaction with max. Nature (Lond.), 359: 423-426, 1992.
13. Hanson, K. D., Shichiri, M., Follansbee, M. R., and Sedivy, J. M. Effects of c-myc expression on cell cycle progression. Mol. Cell. Biol., 14: 5748-5755, 1994.
14. Henriksson, M., and Luscher, B. Proteins of the Myc network: essential regulators of cell growth and differentiation. Adv. Cancer Res., 68: 109-182, 1996.
15. Spencer, C. A., and Groudine, M. Control of c-myc regulation in normal and neoplastic cells. Adv. Cancer Res., 68: 1-48, 1991.
16. Packham, G., and Cleveland, J. L. The role of ornithine decarboxylase in c-myc-induced apoptosis. Curr. Top. Microbiol. Immunol., 194: 283-290, 1995.
17. Galaktionov, K., Chen, X., and Beach, D. cdc25 cell-cycle phosphatase as a target of c-myc. Nature (Lond.), 382: 511-517, 1996.
18. Bhatia, K., Huppi, K., Spangler, G., Siwarski, D., Iyer, R., and Magrath, I. Point mutations in the c-myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas. Nat. Genet., 5: 56-61, 1993.
19. Fellbaum, C., Radaszkiewicz, T., Ruhri, C., Putz, B., Lehmacher, W., and Hofler, H. c-myc mRNA expression in non-Hodgkin's lymphomas. Virchows Arch. B Cell Pathol., 62: 61-68, 1992.
20. Harris, N. L., Jaffe, E. S., Stein, H., Banks, P. M., Chan, J. K., Cleary, M. L., Delsol, G., De Wolf-Peeters, C., Falini, B., Gatter, K. C., Grogan, T. M., Isaacson, P., Knowles, D. M., Mason, D. Y., Muller-Hermelink, H. K., Pileri, S., Piris, M. A., Ralfkiaer, E., and Warnke, R. A. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood, 84: 1361-1392, 1994.
21. Glissin, V., Crkvenjakov, R., and Byus, C. Ribonucleic acid isolated by cesium chloride centrifugation. Biochemistry, 13: 2633-2637, 1974.
22. Bosch, F., Jares, P., Campo, E., Lopez-Guillermo, A., Piris, M. A., Villamor, N., Tassies, D., Jaffe, E. S., Montserrat, E., Rozman, C., and Cardesa, A. Prad-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma. Blood, 84: 2726-2732, 1994.
23. Hedley, D. W., Friedlander, H. L., Taylor, J. W., Rugg, C. A., and Musgrove, E. A. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow-cytometry. J. Histochem. Cytochem., 31: 1333-1335, 1983.
24. Shanicey, T. V., Rabinovitch, P. S., Baqwell, B., Bauer, K. D., Duque, R. E., Hedley, D. W., Mayall, B. H., Wheeless, L., and Cox, C. Guidelines for implementation of clinical DNA cytometry. Cytometry, 14: 472-477, 1993.
25. Hiddemann, W., Schumann, J., Andreef, M. B. B., Herman, C. J., Leif, R. C., Magall, B. H., Hurphy, R. F., and Sandberg, A. A. Convention on nomenclature for DNA cytometry. Cytometry, 5: 445-446, 1986.
26. Gu, Y., Rosenblatt, J., and Morgan, D. O. Cell cycle regulation of cdk2 activity by phosphorylation of thr160 and tyr15. EMBO J., 11: 3995-4005, 1992.
27. Hall, M., and Peters, G. Genetic alterations of cyclins, cyclin-dependent kinases, and cdk inhibitors in human cancer. Adv. Cancer Res., 68: 67-108, 1996.
28. 1 cyclin-dependent kinases. Genes Dev., 9: 1149-1163, 1995.
29. Ott, M. M., Ott, G., Kuse, R., Porowski, P., Gunzer, U., Feller, A. C., and Muller-Hermelink, H. K. The anaplastic variant of centrocytic lymphoma is marked by frequent rearrangements of the bcl-1 gene and high proliferation indices. Histopathology (Oxford), 24: 329-334, 1994.
30. Jares, P., Campo, E., Pinyol, M., Bosch, F., Miquel, R., Fernández, P. L., Sanchez-Beato, M., Soler, F., Perez-Losada, A., Nayach, I., Mallofré, C., Piris, M. A., Montserrat, E., and Cardesa, A. Expression of retinoblastoma gene product (prb) in mantle cell lymphomas. Correlation with cyclin D1 (prad1/ccnd1) mRNA levels and proliferative activity. Am. J. Pathol., 148: 1591-1600, 1996.
31. Lardelli, P., Bookman, M. A., Sundeen, J., Longo, D. L., and Jaffe, E. S. Lymphocytic lymphoma of intermediate differentiation. Morphologic and immunophenotypic spectrum and clinical correlations. Am. J. Surg. Pathol., 14: 752-763, 1990.
32. Velders, G. A., Kluin-Nelemans, J. C., De Boer, C. J., Hermans, J., Noordijk, E. M., Schuuring, E., Kramer, M. H., Van Deijk, W. A., Rahder, J. B., Kluin, P. M., and Van Krieken, J. H. Mantle-cell lymphoma: a population-based clinical study. J. Clin. Oncol., 14: 1269-1274, 1996.
33. Bosch, F., López-Guilermo, A., Campo, E., Ribera, J. M., Conde, E., Piris, M. A., Vallespí, T., Woessner, S., and Montserrat, E. Mantle-cell lymphoma: presenting features, response to therapy, and prognostic factors. Cancer (Phila.), 82: 567-575, 1998.
34. Inghirami, G., Macri, L., Cesarman, E., Chadburn, A., Zhong, J., and Knowles, D. M. Molecular characterization of cd30+ anaplastic large-cell lymphoma: high frequency of c-myc proto-oncogene activation. Blood, 83: 3581-3590, 1994.
35. Yano, T., Jaffe, E. S., Longo, D. L., and Raffeld, M. Myc rearrangements in histologically progressed follicular lymphomas. Blood, 80: 758-767, 1992.
36. Ballerini, P., Gaidano, G., Gong, J. Z., Tassi, V., Saglio, G., Knowles, D. M., and Dalla-Favera, R. Multiple genetic lesions in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Blood, 81: 166-176, 1993.
37. Clark, H. M., Yano, T., Otsuki, T., Jaffe, E. S., Shibata, D., and Raffeld, M. Mutations in the coding region of c-myc in AIDS-associated and other aggressive lymphomas. Cancer Res., 54: 3383-3386, 1994.
38. Marin, M. C., Hsu, B., Stephens, L. C., Brisbay, S., and McDonnell, T. J. The functional basis of c-myc and bcl-2 complementation during multistep lymphomagenesis in vivo. Exp. Cell Res., 217: 240-247, 1995.
39. McDonnell, T. J., and Korsmeyer, S. J. Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18). Nature (Lond.), 349: 254-256, 1991.
40. Lovec, H., Grzeschiczek, A., Kowalski, M. B., and Moroy, T. Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice. EMBO J., 13: 3487-3495, 1994.
41. Bodrug, S. E., Warner, B. J., Bath, M. L., Lindeman, G. J., Harris, A. W., and Adams, J. M. Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. EMBO J., 13: 2124-2130, 1994.
42. Baldin, V., Cans, C., Superti-Furga, G., and Ducommun, B. Alternative splicing of the human CDC25B tyrosine phosphatase. Possible implications for growth control? Oncogene, 14: 2485-2495, 1997.